BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38699440)

  • 1. Loss-of-function
    Kittaka M; Mizuno N; Morino H; Yoshimoto T; Zhu T; Liu S; Wang Z; Mayahara K; Iio K; Kondo K; Kondo T; Hayashi T; Coghlan S; Teno Y; Doan AAP; Levitan M; Choi RB; Matsuda S; Ouhara K; Wan J; Cassidy AM; Pelletier S; Nampoothiri S; Urtizberea AJ; Robling AG; Ono M; Kawakami H; Reichenberger EJ; Ueki Y
    JBMR Plus; 2024 Jun; 8(6):ziae050. PubMed ID: 38699440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.
    Mukai T; Ishida S; Ishikawa R; Yoshitaka T; Kittaka M; Gallant R; Lin YL; Rottapel R; Brotto M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014 Dec; 29(12):2618-35. PubMed ID: 24916406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice.
    Kittaka M; Yoshimoto T; Schlosser C; Kajiya M; Kurihara H; Reichenberger EJ; Ueki Y
    JBMR Plus; 2020 Jun; 4(6):e10352. PubMed ID: 32537546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.
    Yoshitaka T; Kittaka M; Ishida S; Mizuno N; Mukai T; Ueki Y
    Bone; 2015 Feb; 71():201-9. PubMed ID: 25445458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model.
    Mukai T; Gallant R; Ishida S; Yoshitaka T; Kittaka M; Nishida K; Fox DA; Morita Y; Ueki Y
    PLoS One; 2014; 9(8):e105518. PubMed ID: 25144740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.
    Kittaka M; Mayahara K; Mukai T; Yoshimoto T; Yoshitaka T; Gorski JP; Ueki Y
    J Bone Miner Res; 2018 Jan; 33(1):167-181. PubMed ID: 28914985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.
    Yoshimoto T; Hayashi T; Kondo T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2018 Aug; 33(8):1513-1519. PubMed ID: 29669173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tlr2/4-Mediated Hyperinflammation Promotes Cherubism-Like Jawbone Expansion in Sh3bp2 (P416R) Knockin Mice.
    Fujii Y; Monteiro N; Sah SK; Javaheri H; Ueki Y; Fan Z; Reichenberger EJ; Chen IP
    JBMR Plus; 2022 Jan; 6(1):e10562. PubMed ID: 35079675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss.
    Yoshitaka T; Ishida S; Mukai T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014; 29(5):1170-82. PubMed ID: 24978678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
    Ueki Y; Lin CY; Senoo M; Ebihara T; Agata N; Onji M; Saheki Y; Kawai T; Mukherjee PM; Reichenberger E; Olsen BR
    Cell; 2007 Jan; 128(1):71-83. PubMed ID: 17218256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
    Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
    Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function.
    Mukherjee PM; Wang CJ; Chen IP; Jafarov T; Olsen BR; Ueki Y; Reichenberger EJ
    Am J Orthod Dentofacial Orthop; 2010 Aug; 138(2):140.e1-140.e11; discussion 140-1. PubMed ID: 20691350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice.
    Kittaka M; Yoshimoto T; Hoffman H; Levitan ME; Ueki Y
    Bone Rep; 2020 Jun; 12():100258. PubMed ID: 32258251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the SH3BP2 gene in 2 families of cherubism.
    Tuna EB; Shimizu T; Seymen F; Yildirim M; Gencay K; Maeda T
    Pediatr Dent; 2012; 34(3):198-202. PubMed ID: 22795151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGFβ signaling.
    Liu Y; Sharma T; Chen IP; Reichenberger E; Ueki Y; Arif Y; Parisi D; Maye P
    Bone; 2018 Jun; 111():28-35. PubMed ID: 29530719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH3BP2-related fibro-osseous disorders of the maxilla and mandible: A systematic review.
    Kueper J; Tsimbal C; Olsen BR; Kaban L; Liao EC
    Int J Oral Maxillofac Surg; 2022 Jan; 51(1):54-61. PubMed ID: 33941395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of SH3BP2 in the pathophysiology of cherubism.
    Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cherubism as a systemic skeletal disease: evidence from an aggressive case.
    Morice A; Joly A; Ricquebourg M; Maruani G; Durand E; Galmiche L; Amiel J; Vial Y; Cavé H; Belhous K; Piketty M; Cohen-Solal M; Berdal A; Collet C; Picard A; Coudert AE; Kadlub N
    BMC Musculoskelet Disord; 2020 Aug; 21(1):564. PubMed ID: 32825821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.
    Idowu BD; Thomas G; Frow R; Diss TC; Flanagan AM
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):229-230. PubMed ID: 17544554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.